glp 1 low blood pressure GLP-1 for Weight Loss and Diabetes GLP-1 Hypertension: A New Edge
Description
AWARD-1: Dulaglutide vs
Abstract Background
Mailhac A, Pedersen L, Pottegrd A, Sndergaard J, Mogensen T, Srensen HT, Thomsen RW (2024) Semaglutide (Ozempic) Use in Denmark 2018 Through 2023User Trends and off-Label Prescribing for Weight Loss
[DOI] [PubMed] [Google Scholar] 288.Conceicao J., Dores J., Araujo F., Laires P.A., Carr R.D., Brodovicz K., Radican L., Nogueira A.M
While many symptoms improve over time, GI discomfort remains a leading reason for discontinuation, reinforcing the need for gradual dose titration, patient education, and a personalized approach when choosing a GLP-1 therapy
